Lexicon Pharmaceuticals Inc (NAS:LXRX)
$ 0.7734 -0.01075 (-1.37%) Market Cap: 279.58 Mil Enterprise Value: 122.41 Mil PE Ratio: 0 PB Ratio: 1.57 GF Score: 43/100

Q2 2023 Lexicon Pharmaceuticals Inc Earnings Call Transcript

Aug 03, 2023 / 09:00PM GMT
Release Date Price: $1.92 (+1.59%)
Operator

Good day, and welcome to the Lexicon Pharmaceuticals Second Quarter 2023 Financial Results Conference Call. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Carrie Siragusa. Please go ahead.

Carrie Siragusa
Lexicon Pharmaceuticals, Inc. - Executive Director of Corporate Strategy and IR

Thank you, Kim. Good afternoon, and welcome to the Lexicon Pharmaceuticals' Second Quarter 2023 Financial Results Conference Call. Joining me today are Lonnel Coats, Lexicon's Chief Executive Officer; Jeff Wade, Lexicon's President and Chief Financial Officer; and Dr. Craig Granowitz, Lexicon's Senior Vice President and Chief Medical Officer.

Earlier this afternoon, Lexicon issued a press release announcing our financial results for the second quarter of 2023, which is available on our website at www.lexpharma.com and through our SEC filings. A webcast of this call, along with the slide presentation is available on our website.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot